Business Wire

CES Asia: Innovation at the Speed of 5G

Del

CES Asia® 2018 wrapped today with the rapid pace of global innovation front and center over the show’s three day duration. The next stage of technology advancements were showcased across vehicle tech, robotics, artificial intelligence (AI), virtual and augmented reality, digital health and more. The event, 24 percent larger than last year in terms of footprint, cemented itself as the place to fully experience how the pace of technology is accelerating globally. CES Asia, the premier event for tech innovation in the Asian marketplace, will return to Shanghai, China, June 11-13, 2019.

“5G and AI are igniting growth across the entire tech ecosystem changing the way we interact with technology and the world around us,” said Gary Shapiro, president and CEO, Consumer Technology Association (CTA)™. “It’s incredible to see technology refining and reinventing itself at such a fast pace. Just six months ago we were at CES with life-altering tech all around us. This week, I saw that technology refined, enhanced and built upon in many ways, especially with AI and 5G integration and the creative ways those technologies are being imagined and implemented.”

With 43,000 trade attendees and total attendance of over 46,000, including 1,400+ members of the global media, up 20 percent over 2017 total attendance, CES Asia 2018 broke records. More than 500 companies showcased tech breakthroughs across 50,000 gross square meters of exhibit space; a 24 percent increase over 2017 and 2.5 times larger than the inaugural 2015 event.

“CES Asia is the best indicator of consumer technology trends in Asia,” said Lenovo Group. “As a frequent exhibitor at CES, Lenovo Group is exhibiting at CES Asia for the first time and fully demonstrated Lenovo China’s new strategic vision, especially conducting intelligent IoT business and the progress that we’ve achieved. We are very impressed with the show and Lenovo Group will continue to work with CES Asia.”

Conference programming highlighted technology’s role in improving lives, creating jobs and furthering economic growth on a global scale. Industry visionaries took to the CES Asia keynote stage to discuss the future of innovation, including leaders from Alibaba A.I. Labs, BYTON, Hisense, Huawei, Lenovo, as well as China’s Powerful Startup Economy’s panel that featured leaders from Baidu Capital, Horizon Robotics, TouchPal and Volcanics Venture.

The program featured sessions with key executives from global brands including 360 Smart, Aptiv, Deloitte, Intel China, Leapmotor, Lenovo, Suning and TCL. Sessions covered a wide range of industry topics including smart mobility, AI, robotics, new retail, smart cities and autonomous vehicles. The full conference lineup can be viewed here.

"Whether for auto manufacturers or auto consumers, the role of CES Asia in the vehicle industry is increasingly important,” said Marc Mansell, vice president Bose Automotive Systems Division. “We are very excited about Bose’s first time at CES Asia. The new technology demonstrated by Bose is designed to help automakers solve key issues and provided owners with a better driving experience."

Sessions ran for all three days. Leaders from Qualcomm Technologies, Inc., and ZOL discussed new services and devices that will come to market with 5G creating new consumer benefits and opportunities that will accompany this game-changing technology.

Exhibitors launched products and announced partnerships throughout the show. Major announcements include:

  • Baidu Intelligent Vehicle and BMW China announced a cooperation of V2H (Vehicles to Home)
  • Hanergy released high-profile new consumer electronics products such as the thin-film solar charging pack and the thin-film solar backpack
  • Libratone, the audio brand from Denmark, announced the new generation of ZIPP 2 smart wireless audio
  • Hohem released a new generation of stabilizers, iSteady Pro and iSteady Mobile
  • Morpx’s MoonBot is a new AI educational robot kit developed with world leading vision recognition technology
  • PowerVision released a new generation of underwater robot Power Dolphin
  • Shadow Creator announced the launch of three products: Action One, Shadow VR and New Air 2
  • Suning launched Magic Mirror and Biu Speaker and conducted demos for the media

CES Asia is one of the fastest growing tradeshows in Asia and reinforces China’s evolution as an innovation pioneer. For the latest news, photos, b-roll and more, visit CESAsia.com.

Owned and produced by International CES (Shanghai) Exhibition Co. Ltd. and co-produced by Shanghai Intex, CES Asia 2018 ran June 13-15, 2018 in Shanghai, China. The premier event for the consumer technology industry in Asia, CES Asia showcases major brands and innovative companies across several vertical markets in the Asian marketplace.

About CES Asia:

Owned and produced by the International CES (Shanghai) Exhibition Co. Ltd. and co-produced by Shanghai Intex Exhibition Co., Ltd (Shanghai Intex), CES Asia is the premier event for the consumer technology industry, showcasing the full breadth and depth of the innovation value-chain in the Asian marketplace. Key global businesses come to this new event to grow and reinforce their brand by showcasing the latest products and technologies to consumer tech industry executives, foreign buyers, international media and a limited number of consumers from China. Attendees have exclusive access to some of the largest brands from China and around the world, while celebrating the innovation that defines the consumer technology sector.

About International CES (Shanghai) Exhibition Co. Ltd. and CTA:

International CES (Shanghai) Exhibition Co. Ltd. is a wholly foreign-owned enterprise by the Consumer Technology Association (CTA), a trade association representing the $351 billion U.S. consumer technology industry, which supports more than 15 million U.S. jobs. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. CTA also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.

About Shanghai Intex:

Shanghai Intex Exhibition Co., Ltd was originally the exhibition organizing business of Shanghai Intex, a pioneering exhibition organizer established in 1995. Shanghai Intex is jointly overseen by the China Council for the Promotion of International Trade (CCPIT) Shanghai and PNO Exhibition Investment (Dubai) Limited. Starting in 1998, Shanghai Intex has organized over 100 trade shows and conferences with a sum total exhibition space in excess of 2 million sqm. Shanghai Intex is comprised of professional teams with a wealth of experience in organizing major international events, covering the creative industry, healthcare, lifestyle, advanced manufacturing and consumer electronics.

UPCOMING EVENTS

  • CEO Summit
    June 24-27, Barcelona, Spain
  • CES Unveiled Amsterdam
    September 27, Amsterdam, Netherlands
  • Tech & Standard Fall Forum
    October 1-5, Hollywood, CA
  • CES Unveiled Paris
    October 3, Paris, France
  • Innovate Celebrate
    October 15-17, Boston, MA
  • CES Unveiled New York
    November 8, New York, NY
  • CES Unveiled Las Vegas
    January 6, 2019, Las Vegas, NV
  • CES 2019
    January 8-11, 2019, Las Vegas, NV

Contact information

Consumer Technology Association (CTA)
Teresa Hsu

703-907-5259
thsu@CTA.tech
www.CESAsia.com
or
Bernice Morquette
703-907-7651
bmorquette@CTA.tech
www.CES.tech

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

IONITY Fast Charging Network Relies on has·to·be Know-How for the Long Term24.4.2019 10:18:00 CESTPressemelding

The IONITY joint venture aims to help electromobility achieve a breakthrough in Europe with a nationwide network of super-fast charging stations. The Austrian electromobility provider, has·to·be, is playing an important role in this. The red-white-red company will take care of the reliable and trouble-free operation of the charging stations. The two companies have agreed on a long-term cooperation so that the expansion of the Europe-wide network can proceed according to plan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190424005465/en/ has·to·be and IONITY focus on long-term cooperation (Graphic: Business Wire) has·to·be, based in Radstadt (Salzburg), specializes in smart solutions for e-charging stations. For this purpose, the company has developed intelligent software for the management of electrical charging infrastructures. The product is called be.ENERGISED and is used successfully at more than 14,000 charging statio

Knopp Biosciences Receives FDA Orphan Drug Designation for Dexpramipexole for Treatment of Hypereosinophilic Syndrome24.4.2019 10:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with high unmet needs, announced today that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to dexpramipexole, its oral drug candidate for the treatment of hypereosinophilic syndrome (HES). HES is a rare and often incapacitating disorder with limited treatment options. The FDA Orphan Drug Designation program provides a special status to drugs and biologics intended to treat, diagnose, or prevent diseases and disorders that affect fewer than 200,000 people in the U.S. This designation provides for a seven-year marketing exclusivity period against competition, as well as certain incentives, including federal grants, tax credits and a waiver of PDUFA filing fees. “We are very pleased to receive orphan drug designation for dexpramipexole for HES,” said Michael Bozik, M.D., CEO of Knopp Biosc

Enterprise Integration Middleware Leader, Fiorano Software, Announces Release of Fiorano Platform 12.024.4.2019 09:00:00 CESTPressemelding

Fiorano Software, a leader in Integration Middleware, API Management and peer-to-peer distributed systems, announced today the release of version 12.0 of the Fiorano ESB and API Management platform. The latest release with new adapters and tools includes enhanced and optimised features to improve performance of its servers delivering a more productive SOA and API Management deployment with a significant incremental return on investment. The platform offers a unified profile to run all Fiorano Servers in a single process and ships with several new adapters including a Kafka Connector, DynamoDB, AS4Connector, SMPPSend and WebSockets. Users can now import Event Processes directly from the Dashboard and optimize CRC processes by fetching components from local repositories. The new platform provides a new HTML5 dashboard, monetisation and security policies like JWT/JWS for API Management while supporting Open API specifications, OpenId Connect and time-based accessing and quota policies alo

Aptorum Group’s Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT™24.4.2019 08:30:00 CESTPressemelding

Aptorum Group Limited (Nasdaq:APM) is excited to announce the launch and issuance of its asset backed Smart Pharma Token (“SMPT”) by its wholly owned subsidiary group, Smart Pharma group and Smart Pharmaceutical Limited Partnership (“SPLP”) targeted in May 2019. SPLP is extremely pleased to have jointly developed the SMPT token with Aenco, an affiliated blockchain development company focused on applications in the healthcare and financial sector. The SMPT token, an ERC-1404 security compliant token, is a unique token that tokenizes valuable pharmaceutical drugs and their underlying intellectual property and associated allocation of cash flows induced by continual product development and commercialization. It is the intention of the Smart Pharma group to continue to incorporate Aenco’s blockchain technology into its pharmaceutical development and commercialization processes. Relying on intellectual property derived from the Smart-ACT™ platform, Smart Pharma’s in-house new and repurposed

Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases24.4.2019 08:30:00 CESTPressemelding

Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma (“SmartP”), which operates its novel computational repurposed drug discovery, modeling and validation platform, together referred to as the “Smart-ACTTM” platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190424005095/en/ (Photo: Business Wire) Smart-ACTTM stands for Accelerated Commercialization of Therapeutics and encompasses state-of-the-art technology in systematic screening of existing approved drug molecules against selected therapeutic targets. Specifically, the Smart-ACTTM platform comprises of a network of modules and processes that simulate the effectiveness of drug molecules against diseases for outcome prediction and selection. The Smart-ACTTM platform will initially focus on the screening drug molecules for orphan diseases or unmet medical needs. To date, SmartP has, under the recently established

Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 201924.4.2019 08:15:00 CESTPressemelding

Aptorum Group Limited (NASDAQ: APM) (“Aptorum” or the “Company”), a pharmaceutical company focused on the development and commercialization of therapeutic and diagnostic technologies to tackle unmet medical needs, announced today that the Company, in a privately-negotiated transaction, repurchased all outstanding US$13,500,000 in aggregate principal amount of the 8.00 per cent. convertible bonds due 2019 (“Convertible Bonds”) from Peace Range Limited, a wholly owned subsidiary of Adamas Ping An Opportunities Fund LP, together with certain subscription right to subscribe up to the principal amount of the Bond at a US$12.17 (subject to adjustment) on or before December 17, 2019 (“Subscription Right”). The total consideration of the repurchase of the Convertible Bonds and the Subscription Right was US$13.6 million in cash, excluding accrued interest. The repurchase of the Convertible Bonds and Subscription Right was executed by Aptorum Investment Holding Limited, a wholly owned subsidiary